A recent study suggests that a deficiency of a protein in the brain of Down syndrome patients could contribute to the cognitive impairment and congenital heart defects that characterize the syndrome.
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
People with Alzheimer’s disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
For more than 30 years, scientists have known that multiple sclerosis (MS) is much more common in higher latitudes than in the tropics. Because sunlight is more abundant near the equator, many researchers have wondered if the high levels of vitamin D engendered by sunlight could explain this unusual pattern of prevalence.
The American Academy of Neurology has issued a new guideline recommending the most effective treatments to help people with Parkinson’s disease who experience sleep, constipation, and sexual problems, which are common but often underrecognized symptoms. The guideline is published in the March 16, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.
African-American, Hispanic, and economically disadvantaged patients with brain tumors are significantly less likely to be referred to high-volume hospitals that specialize in neurosurgery than other patients of similar age, the same gender, and with similar comorbidities, according to new research by Johns Hopkins doctors. The finding, published in the March Archives of Surgery, suggests a scenario in direct contrast to recommendations from federal health care agencies encouraging better access and quality of health care for people of all races.
A family history of Alzheimer’s is one of the biggest risk factors for developing the memory-robbing disease, which affects more than 5 million Americans and is the most common form of senile dementia. Now an international collaboration led by NYU Langone Medical Center researchers has found the likely basis for this heightened familial risk—especially from the maternal side.
On March 21, Benny Zafrani will be running the Los Angeles Marathon. That, by itself, is not remarkable – after all, thousands of others will be doing the same thing. However, Benny is on a mission to raise funds for pediatric brain tumor research. And his mission was spurred by personal experience.
Regularly participating in activities, like sports, can increase the risk of head injury. Physical blows to the head, even mild ones, can be common causes of traumatic brain injuries (TBIs). Dr. Todd Trask, neurosurgeon at the Methodist Neurological Institute, cautions those who participate in activities where head injuries are a possibility, and offers tips on how to protect the head and prevent injuries. (Note: March is National Brain Injury Awareness Month.)
New research from Vanderbilt University reveals for the first time how our brains coordinate two different types of attention and why we may be temporarily blinded by surprises.
Researchers have new insight into the relationship between Parkinson’s disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson’s disease. A new study published in the March 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology, shows that smoking for a greater number of years may reduce the risk of the disease, but smoking a larger number of cigarettes per day may not reduce the risk.
Many Americans will lose an hour of sleep on March 14, the first day of daylight-saving time—making it harder to wake up, causing difficulty in staying alert and increasing the chance of sleepy-driving car crashes. However, this is not the only time when the amount of sleep should be of concern because many aspects of health are related to sleep. Read on for more information.
Two winners have been selected for the Promising New Investigators Travel Scholarship Awards given annually by the Neuroleptic Malignant Syndrome Information Service (NMSIS).
Researchers at Cedars-Sinai Medical Center in Los Angeles, the University of California, San Diego School of Medicine, and UTHealth’s Medical School will collaborate on the largest clinical trial of hypothermia (brain cooling) for stroke to date. The ICTuS 2 study (Intravascular Cooling for Acute Stroke) will be led by overall principal investigator Patrick D. Lyden, M.D., former director of the UC San Diego Stroke Center and currently chairman of the Department of Neurology at Cedars-Sinai.
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a report posted online today that will appear in the May print issue of Archives of Neurology, one of the JAMA/Archives journals.
Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
In a far-reaching dialogue, three pioneering researchers -- Nicholas Spitzer, Kwabena Boahen and Hongkun Park -- discuss the synergy between nanoscience and neuroscience, what it means for the future, and how it is driving current research.
Having a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Michael J. Friedlander, the Wilhelmina Robertson Professor and chair of the Department of Neuroscience and the director of Neuroscience Initiatives at the Baylor College of Medicine, has been named founding executive director of the Virginia Tech Carilion Research Institute.
University of Nebraska Medical Center researchers have taken a significant step in developing a vaccination approach to reverse the neurological damage seen with Parkinson's disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right